子宫动脉栓塞术在剖宫产术后子宫瘢痕妊娠治疗中的应用

目的探讨子宫动脉栓塞术(UAE)在剖宫产术后子宫瘢痕妊娠(CSP)治疗中的应用价值。方法 2007年1月至2011年6月共收治CSP患者35例,根据是否行UAE分为栓塞组(21例)和非栓塞组(14例)。栓塞组中,16例在UAE后24～48 h行清宫术,5例在UAE后行开腹或阴式病灶切除术。非栓塞组中8例直接行清宫术,3例病灶局部注射甲氨蝶呤后行清宫术,3例直接开腹行病灶切除术。比较两组患者术中出血量、住院时间、β-人绒毛膜促性腺激素(β-HCG)值降至正常时间的差异。结果栓塞组21例患者UAE操作成功,全部患者保留子宫,平均住院时间为(11.5±3.6)d,β-HCG值降至正常的平均时间为(18.6±4.9)d,而非栓塞组则分别为(20.4±5.2)d和(28.7±5.6)d。非栓塞组中2例由于术中出血汹涌,被迫行子宫切除术。结论 UAE术是一种有效的治疗CSP的方法,创伤小、成功率高,保留了患者的生育功能,能起到明显的防止出血和止血的作用。     

腹腔镜联合子宫动脉栓塞术治疗外生型剖宫产瘢痕妊娠的疗效

目的 探讨腹腔镜联合子宫动脉栓塞术(uterine artery embolization,UAE)用于治疗外生型剖宫产术后瘢痕妊娠(cesarean scar pregnancy,CSP)的应用价值.方法 回顾性分析了北京军区总医院2010-01至2015-07收治的14例应用腹腔镜联合UAE治疗的外生型CSP患者的临床表现、诊断、治疗及疗效.结果 术前行UAE的13例患者腹腔镜下首次治疗成功,术后2～5d复查血HCG,HCG检测结果为25.9～ 5657.0 mU/L,平均为2094.5 mU/L;同术前相比,平均下降89.64％±11.55％.术前未行UAE的1例患者术中因出现大出血而急诊输血+中转开腹行瘢痕病灶切除术+子宫动脉栓塞术.14例均治愈出院且无复发.结论 腹腔镜联合UAE治疗外生型CSP较直观、安全、有效,术前应用UAE能有效减少术中出血,术中应用UAE能有效控制出血.     

剖宫产疤痕妊娠的子宫动脉栓塞并清宫治疗

目的 探讨子宫动脉栓塞后清官对剖宫产疤痕妊娠(cesarean scar pregnancies,CSP)的治疗价值.资料与方法 对14例CSP患者行子宫动脉栓塞后在超声引导下清宫,记录手术时和术后阴道出血量、有无术后残留及再发出血,并随访月经及再次妊娠情况.结果 14例术中出血5～20 ml,平均11.5 ml,术后均无宫内残留,无再发出血.有2例再次怀孕,1例孕11周行人流,1例孕33+2周产下一健康男婴.结论 子宫动脉栓塞后清宫既能控制出血量,又保留了女性生育机能,是治疗CSP的一种安全、有效的方法,但对其他类型CSP的治疗价值有待探讨.     

子宫动脉栓塞术治疗有异常供血的剖宫产瘢痕妊娠临床研究

【摘要】 目的 探讨有异常供血的剖宫产瘢痕妊娠（CSP）产妇子宫动脉栓塞术（UAE）治疗效果。 方法 分析92例接受UAE术CSP患者临床和DSA影像资料。其中15例妊娠囊有除子宫动脉以外的异常供血患者为A组,77例无异常供血患者为B组。比较两组患者UAE术后24 h血清β-人绒毛膜促性腺激素（β-HCG）下降程度、术中大出血、输血率、UAE后住院时间、血清β-HCG转阴时间、UAE操作时间和月经恢复时间。 结果 A、B组UAE术技术成功率均为100%。A组共计20支异常供血血管中16支成功完成超选择性插管并栓塞,4支超选择性插管失败后改行髂内动脉前干栓塞。除3例（B组）拒绝接受UAE术后治疗外,89例于UAE术后1～13 d接受妊娠囊清除术,术中出血5～1 400 mL,无子宫切除事件发生。A、B组间术中大出血、输血率、UAE操作时间差异有统计学意义（P＜0.05）,UAE术后24 h血清β-HCG下降程度、UAE后住院时间、血清β-HCG转阴时间和月经恢复时间差异无统计学意义（P＞0.05）。 结论 UAE治疗有异常供血的CSP患者效果满意。需要注意的是,UAE成功施行后妊娠囊清除手术过程中仍有大出血可能,仍需临床加以重视。     

子宫动脉化疗栓塞术在剖宫产瘢痕妊娠保守治疗中的作用

目的：探讨双侧子宫动脉化疗栓塞术在剖宫产瘢痕妊娠保守治疗中的作用。方法：回顾性分析我院自2007年1月-2009年3月临床确诊的剖宫产术后瘢痕妊娠患者38例,均合并程度不等阴道出血。其中28例出血相对较重患者行双侧子宫动脉氨甲喋呤灌注化疗及明胶海绵颗粒栓塞,术后第2-4天行人工流产（吸-刮宫术）,10例轻症患者药物保守治疗4-7 d后行吸-刮宫术。结果28例行双侧子宫动脉MTX化疗灌注及栓塞术的患者阴道出血迅速停止,吸-刮宫术中及术后出血量均少于100 ml。10例药物保守治疗患者中,5例吸刮宫术中大出血（其中1例子宫切除,4例行急诊子宫动脉栓塞止血）,5例出血少于1000 ml,采用宫缩剂、宫内填塞及输血等措施,出血逐渐停止。结论：双侧子宫动脉化疗栓塞术结合吸-刮宫术能快速终止妊娠,有效预防大出血,保留患者子宫,可以作为治疗此类疾病的常规保守治疗方法。     

子宫动脉化疗栓塞术和子宫动脉栓塞术治疗子宫瘢痕妊娠的临床效果比较

目的：比较子宫动脉化疗栓塞术和子宫动脉栓塞术治疗剖宫产术后子宫瘢痕妊娠（cesarean scar pregnancy,CSP）的疗效。 方法：回顾分析山西医科大学第一医院2007年1月—2016年5月收治的诊断明确的CSP患者71例,分为A组33例和B组38例,A组行子宫动脉化疗栓塞术后行清宫术,B组行子宫动脉栓塞术后行清宫术。比较2组患者清宫过程的出血量、β-人绒毛膜促性腺激素（HCG）值下降至正常的时间及住院时间。 结果：2组患者的治疗成功率为100%,清宫过程中的出血量：A组为（40±30）ml,B组为（50±20）ml,差别无统计学意义。β-HCG值下降至正常的时间：A组为（16±3）d,低于B组的（21±5）d,差别有统计学意义。住院时间：A组为（11±3）d,低于B组的（13.5±4.5）d,差别有统计学意义。 结论：子宫动脉化疗栓塞术和子宫动脉栓塞术治疗CSP的成功率、清宫过程的出血量无明显差别,但子宫动脉化疗栓塞术能缩短患者的β-HCG值下降至正常的时间和住院时间。     

双侧子宫动脉化疗栓塞术治疗剖宫产后瘢痕妊娠大出血的临床应用

目的 探讨剖宫产后子宫瘢痕妊娠(CSP)大出血急诊双侧子宫动脉化疗栓塞术的应用价值.方法 16例CSP大出血患者平均出血量(2 200±1 400)ml,采用Seldinger法先行猪尾导管腹主动脉造影,明确是否为双侧子宫动脉出血后,选择或超选择性插管,造影证实后分别经导管于双侧子宫动脉内灌注5-Fu或MTX和明胶海绵条栓塞.结果 16例CSP大出血患者全部栓塞成功,随访3～6个月无再次大出血.结论 急诊双侧子宫动脉化疗栓塞术治疗CSP大出血既安全、有效,又无严重并发症,值得临床推广使用.     

子宫动脉灌注化疗及栓塞在治疗剖宫产切口瘢痕妊娠中的应用价值

目的探讨经子宫动脉灌注化疗及栓塞术治疗剖宫产切口瘢痕妊娠的应用价值。方法 23例剖宫产后切口瘢痕妊娠病例,在DSA引导下经双侧子宫动脉按血供比例分配灌注甲氨蝶呤100mg进行灌注杀胚,再以明胶海绵栓塞,术后24～48h行清宫术。结果全部病例均顺利完成双侧子宫动脉灌注化疗及栓塞术,术后24h复查血清β-HCG水平较术前平均下降87.77%,阴道出血停止,清宫术中出血10～200ml,平均40ml,无严重并发症发生。结论经子宫动脉灌注可明显提高胚囊局部甲氨蝶呤的血药浓度,有效杀伤和消除胚胎组织,栓塞后阻断胚胎血供,达到降低子宫切除和丧失生育能力的风险,缩短住院时间,是治疗剖宫产切口瘢痕妊娠安全、有效的方法。     

子宫动脉化疗栓塞联合清宫术治疗剖宫产瘢痕部位妊娠

目的 评价经子宫动脉灌注化疗、栓塞联合清官术治疗剖宫产瘢痕部位妊娠的疗效.方法 64例剖官产瘢痕部位妊娠患者(停经43～84 d)行超选择性双侧子宫动脉插管、造影、灌注化疗甲氨蝶呤(MTX)、明胶海绵颗粒栓塞后联合清官术进行治疗.结果 64例患者均插管灌注及栓塞成功,62例术后24～48 h内均顺利清出妊娠组织,清官术中出血平均21.4 ml,2例行病灶切除+子宫下段修补术.术后无严重并发症.结论 子官动脉灌注化疗、动脉栓塞联合清官术治疗刮宫产瘢痕部位妊娠是一种微创、安全、有效并值得推广的方法.     

子宫动脉化疗输注加栓塞术治疗剖宫产后子宫切口妊娠

目的:探讨子宫动脉化疗输注加栓塞术对剖宫产后子宫切口妊娠的应用价值。方法:对9例剖宫产后子宫切口妊娠患者急诊行双侧子宫动脉超选择性插管,输注氨甲喋呤(MTX)后,再用明胶海绵颗粒栓塞双侧子宫动脉,1周内再在B超引导下行刮宫术或吸宫术。结果:9例患者均成功施行了子宫动脉化疗输注加栓塞术,1周内顺利行刮宫术或吸宫术,术中出血量少。结论:子宫动脉化疗输注加栓塞术为剖宫产后子宫切口妊娠患者的保守治疗提供了安全保障,使患者避免子宫被切除,是一种安全、有效的治疗方法。     

Uterine Artery Embolization Combined with Local Methotrexate and Systemic Methotrexate for Treatment of Cesarean Scar Pregnancy with Different Ultrasonographic Pattern

Purpose

This study was designed to compare the effectiveness of systemic methotrexate (MTX) with uterine artery embolization (UAE) combined with local MTX for the treatment of cesarean scar pregnancy (CSP) with different ultrasonographic pattern, and to indicate the preferable therapy in CSP patients.

Methods

The results of 21 CSP cases were reviewed. All subjects were initially administrated with systemic MTX (50?mg/m² body surface area). UAE combined with local MTX was added to the patients who had failed systemic MTX. The transvaginal ultrasonography data were retrospectively assessed, and two different ultrasonographic patterns were found: surface implantation and deep implantation of amniotic sac. The management and its effectiveness for patients with the two ultrasonographic patterns were studied retrospectively. Ultrasound scan and serum ??-hCG were monitored during follow-up. Data were analyzed with the Student??s t test.

Results

Nine patients were successfully treated with systemic MTX. The remaining 12 cases were successfully treated with additional UAE combined with local MTX. According to the classification by Vial et al. of CSP on ultrasonography, most surface implanted CSPs (8/11, 72.7%) could be successfully treated with systemic MTX, whereas most deeply implanted CSPs (9/10, 90%) had failed systemic MTX but still could be successfully treated with additional UAE combined with local MTX. All patients recovered without severe side effects. Most patients with a future desire for reproduction achieved subsequent pregnancy.

Conclusions

For CSP patients suitable for nonsurgical treatment, UAE combined with local MTX would be the superior option compared with systemic MTX in the cases with deep implantation of amniotic sac.     

Uterine Artery Embolization Combined with Methotrexate in the Treatment of Cesarean Scar Pregnancy: Results of a Case Series and Review of the Literature

PurposeTo explore the clinical value of uterine artery embolization (UAE) combined with methotrexate in the treatment of cesarean scar pregnancy (CSP) before and after uterine curettage.Materials and MethodsFrom August 2009 to April 2012, 15 patients with CSP treated with UAE (before or after uterine curettage) were analyzed retrospectively. Eleven subjects with a definite diagnosis of CSP were offered preventive UAE combined with methotrexate before uterine curettage. The other four patients, who were misdiagnosed as having an intrauterine pregnancy, were treated with emergency UAE for uncontrollable massive hemorrhage after uterine curettage. Clinical data, treatment sequence, and outcome were analyzed, and a brief review of the published literature summarizing UAE in the treatment of CSP was performed.ResultsEleven patients with definite CSP received preventive UAE combined with methotrexate followed by uterine curettage, and CSP was resolved successfully without hysterectomy. In the four misdiagnosed patients, three were treated successfully with emergency UAE. The other patient underwent uterine curettage and emergency UAE followed by repeat curettage, but hysterectomy was performed because of continued severe hemorrhage.ConclusionsBased on a small number of patients, it appears that UAE may be an effective means of treating CSP, including treatment in an emergency setting. Further study is required before the safety and effectiveness of UAE can be confirmed.     

Prophylactic Uterine Artery Embolization Assisted Cesarean Section for the Prevention of Intrapartum Hemorrhage in High-Risk Patients

Purpose

To evaluate the safety and efficacy of prophylactic uterine artery embolization (UAE)-assisted cesarean section for the prevention of intrapartum hemorrhage.

Materials and Methods

Twelve consecutive pregnant women (mean age 31 years; range 25–38) with uterine scarring and placenta previa and/or placenta accreta underwent UAE in conjunction with cesarean section to prevent intrapartum hemorrhage. For UAE, the left uterine artery was catheterized prophylactically under fluoroscopic guidance before the cesarean section incision was made. After the infant had been delivered, bilateral UAE was performed with the placenta still in situ. After successful bilateral UAE, the placenta was detached from the uterine wall.

Results

Technical success was achieved in all 12 cases. Ten patients retained their uterus, and the other 2 underwent hysterectomy. The mean operative blood loss was 1,391 mL (range 600–3,600 mL). The total mean fluoroscopy time and mean absorbed dose (air kerma) were 9 min 40 s (range 4 min 35 s–15 min 24 s) and 91.79 mGy (range 30.2–171), respectively. The average fetal fluoroscopy time was 1 min 42 s (range 41 s to 3 min 16 s) with an average X-ray dose of 17.66 mGy (range 6.04–23.90).

Conclusion

UAE-assisted cesarean section is safe and effective in the prevention of intrapartum hemorrhage in patients with uterine scarring and/or placental abnormalities.     

瘢痕妊娠导致大出血的介入治疗

目的：探讨经导管双侧子宫动脉栓塞后清宫治疗瘢痕妊娠导致大出血的临床价值。方法：采用介入结合清宫的方法治疗7例瘢痕妊娠患者,用5F cobra导管导管经股动脉超选择插管至双侧子宫动脉灌注MTX（甲氨蝶呤）100 mg,然后用明胶海绵屑栓塞双侧子宫动脉,于3～5 d行清宫术。结果：7例患者均一次手术成功,术中未见出血,随访2～6个月无异常。结论：采用介入栓塞后清宫治疗瘢痕妊娠导致大出血安全有效,方法简单,不良反应小成功率极高,可有效预防和控制子宫破裂出血,是治疗瘢痕妊娠导致大出血的优选方法之一。     

子宫动脉栓塞治疗子宫肌瘤的临床应用研究

分析子宫动脉栓塞治疗子宫肌瘤的有效性和安全性。材料和方法：５１例子宫肌瘤行子宫通读动脉栓塞治疗,分别于栓塞后１、３、６、１２个月行Ｂ超随访肿瘤体积变化。结果：现例均无子宫坏死一严重并发症。栓塞后６个月,肿瘤体积缩小大于５０％、２０％￣５０％和小于２０％者分别为４１例（占８０．４％）、９例（１７．６％）和１例（占２％）,其中２例肿瘤全部消失。所有病例临床症状减轻或消失。４例自然受孕。结论：子宫动脉栓     

选择性子宫动脉栓塞治疗子宫肌瘤的临床分析

本院自2000年开展经皮选择性子宫动脉栓塞治疗子宫肌瘤技术,已完成66例子宫肌瘤的栓塞治疗,已初见成效.现将治疗作回顾性分析.